Biotech
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/22/13 -- Portola Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 8,422,758 shares of its common stock at a price to ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwired) -- 05/22/13 --$2.4M fondaparinux profit share recorded for quarter ending 31 March 2013Establishment of a collaboration with Merck Serono SA to support an investig ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 05/21/13 -- Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class tar ...
REDWOOD CITY, CA: Plenary Sessions Led by Industry Leaders in the Life Sciences Anchor 2 Days of Thought Provoking Program ...
HUDSON, NY: HUDSON, NY -- (Marketwired) -- 05/20/13 -- Taconic, a global leader in the acquisition, custom generation, breeding, and distribution of genetically engineered mouse and rat research models, announce ...
CHICAGO, ILLINOIS: CHICAGO, ILLINOIS -- (Marketwired) -- 05/20/13 -- Bio-Solutions Corporation (OTCBB: BISU)(PINKSHEETS: BISU) is announcing today that Chicago Bears quarterback Jay Cutler is currently looking over an ...
CHICAGO, ILLINOIS: CHICAGO, ILLINOIS -- (Marketwired) -- 05/20/13 -- (OTCQB: BISU) (PINKSHEETS: BISU) - Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal proposed by Bio-Solutions Corp ...
TUSTIN, CA: Phase III Registration Trial of Investigational Immunotherapy Expected to Start by Year-End ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 05/20/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima," the "Company") has announced today that Matthew Lehman, ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 05/20/13 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that, through its wholly-owned subsidiary Phenogen Sciences Inc., it ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/17/13 -- Med BioGene Inc. (TSX VENTURE: MBI) today, at the request of the Investment Industry Regulatory Organization of Canada (IIROC), announced ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwired) -- 05/17/13 -- (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect against radiolo ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 05/16/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") has announced in pursuant to shareholder ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 05/16/13 -- Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE: IMV), a clinical stage vaccine company, today released its financ ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/16/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that Mr. Mark Beaudet, interim President & CEO ...
TUSTIN, CA: Presentations Include Data From Two Phase II Bavituximab Trials in Second-Line NSCLC and Pancreatic Cancer and a Phase I Bavituximab Trial in HER2-Negative Breast Cancer ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 05/16/13 -- Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announced toda ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 05/16/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced that t ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 05/16/13 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today announced that i ...
SAN DIEGO, CA: CEO of HeartWare International, Inc. and Former CFO of Amgen Elected to Board of Directors ...
